Centiva Capital »

Cytomx Therapeutics shares owned by Centiva Capital

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Centiva Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $940k 200k 4.70

More positions owned by Centiva Capital

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Tesla Motors (TSLA)
Apple (AAPL)
Netflix (NFLX)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Ishares Tr China Lg-cap Etf (FXI)
Ishares Silver Tr Ishares Call Option (SLV)
Spdr Series Trust State Street Spd (KRE)

View all positions for Centiva Capital

Top funds holding Cytomx Therapeutics

FMR
Kynam Capital Management
Bank of America Corporation
Perceptive Advisors
VR Adviser
Vanguard Capital Management
Vanguard Group
Point72 Asset Management
Citadel Advisors
BlackRock
State Street Corporation
Baker Bros. Advisors
Elmind Capital
Nextech Invest
Financial Engines Advisors L.L.C

View all funds holding Cytomx Therapeutics